HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323 | +12.5% | 2,791 | 0.0% | 0.02% | +20.0% |
| Q2 2023 | $287 | -5.9% | 2,791 | 0.0% | 0.02% | -11.8% |
| Q1 2023 | $305 | -82.3% | 2,791 | -81.6% | 0.02% | -83.3% |
| Q4 2022 | $1,723 | -99.8% | 15,144 | 0.0% | 0.10% | +61.9% |
| Q3 2022 | $937,000 | -22.4% | 15,144 | 0.0% | 0.06% | -22.2% |
| Q2 2022 | $1,208,000 | -24.2% | 15,144 | 0.0% | 0.08% | -19.0% |
| Q1 2022 | $1,593,000 | -2.4% | 15,144 | 0.0% | 0.10% | -3.8% |
| Q4 2021 | $1,632,000 | -10.1% | 15,144 | -5.0% | 0.10% | -13.3% |
| Q3 2021 | $1,816,000 | +21.6% | 15,948 | 0.0% | 0.12% | +21.2% |
| Q2 2021 | $1,493,000 | +1.7% | 15,948 | 0.0% | 0.10% | -5.7% |
| Q1 2021 | $1,468,000 | +25.8% | 15,948 | 0.0% | 0.10% | +15.4% |
| Q4 2020 | $1,167,000 | -2.1% | 15,948 | +3.9% | 0.09% | -10.8% |
| Q3 2020 | $1,192,000 | +73.5% | 15,350 | +24.3% | 0.10% | +18.6% |
| Q2 2020 | $687,000 | +24.2% | 12,353 | -33.8% | 0.09% | -30.1% |
| Q1 2020 | $553,000 | -25.6% | 18,669 | -9.0% | 0.12% | -19.6% |
| Q4 2019 | $743,000 | +32.9% | 20,517 | 0.0% | 0.15% | +33.0% |
| Q3 2019 | $559,000 | – | 20,517 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |